A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System. — FDA record Z-1506-2025

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jan 9, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.
Reason
Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.
Classification
Class II
Recalling firm
Medtronic Neuromodulation
Quantity
4365 units
Agency-reported status
Ongoing
Source record identifier
Z-1506-2025

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityversion v.2x, UDI/DI 00763000632793

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, United Kingdom.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Apr 9, 2025
Recall initiation date
Jan 9, 2025
Center classification date
Apr 1, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records